Vaccine Vector
Biocompatible polymer enhances transfection efficiency of HVJ envelope vector
Published in Gene Therapy Weekly, December 15th, 2005
According to a study from Japan, "Vector development is critical for the advancement of human gene therapy. However, the use of viral vectors raises many safety concerns and most non-viral methods are less efficient for gene transfer. One of the breakthroughs in vector technology is the combination of the vector with various polymers. HVJ (hemagglutinating virus of Japan) envelope vector (HVJ-E) has been developed as a versatile gene transfer vector. In this study, we combined HVJ-E with cationized gelatin to make it a more powerful tool and assessed its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-12-15)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
HER-2 protein expression can be inhibited in ovarian cancer cells - DNA Research
Double-stranded RNA induces sequence-specific antiviral silencing - Gene Therapy
Xenopus orthologue of the Treacher Collins syndrome gene product cloned - Hepatitis C Virus
Liver-directed IFN-gamma gene delivery does not control HCV replication - Stem Cell Research
DNA methylation silences a translocase in embryonic stem and germ cells - Apoptosis
Programmed cell death pathways targeted with experimental therapeutics - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
